Arcturus Therapeutics Ltd (ARCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 41,673 | 49,859 | 38,012 | 30,855 | 45,140 |
| Gross Profit | 41,673 | 49,859 | 38,012 | 30,855 | 45,140 |
| Operating Expenses | 52,410 | 70,985 | 68,424 | 49,127 | 64,454 |
| Operating Income | -10,737 | -21,126 | -30,412 | -18,272 | -19,314 |
| Interest Expense | -3,818 | -4,148 | 53 | -9,686 | -3,981 |
| Other Income | -201 | -388 | 4,016 | -2,859 | 4 |
| Pre-tax Income | -7,120 | -17,366 | -26,449 | -11,445 | -15,329 |
| Income Tax | -217 | -150 | 368 | 262 | 893 |
| Net Income Continuous | -6,903 | -17,216 | -26,817 | -11,707 | -16,222 |
| Net Income | $-6,903 | $-17,216 | $-26,817 | $-11,707 | $-16,222 |
| EPS Basic Total Ops | -0.26 | -0.64 | -1.00 | -0.44 | -0.61 |
| EPS Basic Continuous Ops | -0.26 | -0.64 | -1.00 | -0.44 | -0.61 |
| EPS Diluted Total Ops | -0.26 | -0.64 | -1.00 | -0.40 | -0.61 |
| EPS Diluted Continuous Ops | -0.26 | -0.64 | -1.00 | -0.40 | -0.61 |
| EPS Diluted Before Non-Recurring Items | -0.26 | -0.64 | -1.00 | -0.32 | -0.61 |
| EBITDA(a) | $-9,825 | $-20,217 | $-29,508 | $-17,457 | $-18,487 |